{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:30:34Z","timestamp":1784305834199,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.diagmicrobio.2016.06.017","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T16:15:20Z","timestamp":1466698520000},"page":"76-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012\u20132014)"],"prefix":"10.1016","volume":"86","author":[{"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/ciq067","article-title":"Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy","volume":"52","author":"Chua","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0010","series-title":"M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard- tenth edition","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0015","series-title":"M100-S26. Performance standards for antimicrobial susceptibility testing: 26th informational supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-148-4-200802190-00204","article-title":"Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men","volume":"148","author":"Diep","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-013-0075-6","article-title":"Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia","volume":"73","author":"Frampton","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.279.8.593","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk","volume":"279","author":"Herold","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0045","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2165\/11635660-000000000-00000","article-title":"Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections","volume":"72","author":"Lodise","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JCM.01384-09","article-title":"Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from Phase IV clinical trial for linezolid","volume":"48","author":"Mendes","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/528716","article-title":"Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?","volume":"46","author":"Popovich","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0060","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1017\/ice.2015.213","article-title":"Evolving Epidemiology of Staphylococcus aureus Bacteremia","volume":"36","author":"Rhee","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0065","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/AAC.00484-13","article-title":"Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin or vancomycin from USA hospitals (2008\u20132011)","volume":"57","author":"Sader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/INF.0000000000000307","article-title":"Ceftaroline activity tested against bacterial isolates from pediatric patients: Results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011\u20132012)","volume":"33","author":"Sader","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2015.01.015","article-title":"Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013","volume":"82","author":"Sader","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0080","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/AAC.04614-14","article-title":"Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program","volume":"59","author":"Sader","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0085","doi-asserted-by":"crossref","DOI":"10.1089\/sur.2015.209","article-title":"Antimicrobial activity of ceftaroline tested against Staphylococcus aureus from surgical skin and skin structure infections in US Medical Centers","author":"Sader","year":"2016","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0090","author":"TEFLARO\u00ae Package Insert"},{"key":"10.1016\/j.diagmicrobio.2016.06.017_bb0095","author":"Tygacil"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316301778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316301778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T02:23:18Z","timestamp":1536632598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316301778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0732889316301778"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.06.017","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012\u20132014)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}